慢性高血压:妊娠早期血压控制与重度高血压、子痫前期及小于胎龄儿发生风险的关系
该前瞻性研究纳入586例孕前慢性高血压单胎孕妇,按孕早期首次就诊时是否使用降压药及血压是否达标分为三组。三组重度高血压、早产型子痫前期和小于胎龄儿发生率随血压控制恶化而显著升高,足月子痫前期无显著差异。
要点
- 孕早期首次就诊时使用降压药或血压未达标者,重度高血压、早产型子痫前期和小于胎龄儿风险更高。
- 三组重度高血压发生率分别为10.6%、22.2%和52.1%,呈显著递增趋势。
- 足月子痫前期发生率在三组间无显著差异(9.5%、9.1%、6.6%)。
核心结论
- 孕前慢性高血压孕妇重度高血压、早产型子痫前期和小于胎龄儿的发生率与孕早期首次就诊时是否使用降压药及血压控制水平相关。
研究设计与样本
- 前瞻性研究纳入586例孕前慢性高血压、无肾或肝疾病的单胎孕妇,在妊娠期高血压管理专病门诊就诊。
- 按孕早期首次就诊情况分为三组:组1(n=199)未用降压药且血压<140/90 mm Hg;组2(n=220)用降压药且血压<140/90 mm Hg;组3(n=167)用降压药但收缩压≥140 mm Hg和/或舒张压≥90 mm Hg。
- 后续管理策略为用降压药维持血压130-140/80-90 mm Hg,若血压持续<130/80 mm Hg则停用降压药。
主要发现
- 首次就诊中位孕周为10.0周(四分位距9.1-11.0周)。
- 组2和组3较组1体重指数更高、黑人种族比例更高、既往子痫前期病史更多。
- 重度高血压发生率从组1到组3显著升高:组1 10.6% vs 组2 22.2% vs 组3 52.1%。
- 早产型子痫前期(<37周起病)发生率从组1到组3显著升高:组1 7.0% vs 组2 15.9% vs 组3 20.4%。
- 小于胎龄儿发生率从组1到组3显著升高:组1 13.1% vs 组2 17.7% vs 组3 21.1%;足月子痫前期(≥37周起病)三组分别为9.5%、9.1%、6.6%,无显著差异。
关键数值与推荐
- 重度高血压定义:收缩压≥160 mm Hg和/或舒张压≥110 mm Hg。
- 子痫前期定义:除高血压外,至少具备肾脏受累、肝损害、神经系统并发症或血小板减少之一。
- 小于胎龄儿定义:出生体重低于同胎龄第5百分位。
临床怎么用
- 本研究中心的做法是使用降压药将血压维持在130-140/80-90 mm Hg,若血压持续<130/80 mm Hg则停用降压药。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is extensive evidence that prepregnancy chronic hypertension is associated with a high risk of development of severe hypertension and preeclampsia and birth of small-for-gestational-age neonates. However, previous studies have not reported whether antihypertensive use, blood pressure control, or normalization of blood pressure during early pregnancy influences the rates of these pregnancy complications. OBJECTIVE: The purpose of this study was to stratify women with prepregnancy chronic hypertension according to the use of antihypertensive medications and level of blood pressure control at the first hospital visit during the first trimester of pregnancy and to examine the rates of severe hypertension, preeclampsia, and birth of small-for-gestational-age neonates according to such stratification. STUDY DESIGN: We conducted a prospective study of 586 women with prepregnancy chronic hypertension, in the absence of renal or liver disease, that was booked at a dedicated clinic for the management of hypertension in pregnancy. The patients had singleton pregnancies and were subdivided according to findings in their first visit: group 1 (n=199), blood pressure <140/90 mm Hg without antihypertensive medication; group 2 (n=220), blood pressure <140/90 mm Hg with antihypertensive medication; and group 3 (n=167), systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg, despite antihypertensive medication. In the subsequent management of these pregnancies, our policy was to maintain the blood pressure at 130-140/80-90 mm Hg with the use of antihypertensive medication; antihypertensive drugs were stopped if the blood pressure was persistently <130/80 mm Hg. The outcome measures were severe hypertension (systolic blood pressure ≥160 mm Hg and/or diastolic blood pressure ≥110 mm Hg), preterm and term preeclampsia (in addition to hypertension at least 1 of renal involvement, liver impairment, neurologic complications, or thrombocytopenia), and birth of small-for-gestational-age neonates (birthweight <5th percentile for gestational age). The incidence of these complications was compared in the 3 strata. RESULTS: The median gestational age at presentation was 10.0 weeks (interquartile range, 9.1-11.0 weeks). In groups 2 and 3, compared with group 1, there was a significantly higher body mass index, incidence of black racial origin, and history of preeclampsia in a previous pregnancy. There was a significant increase from group 1 to group 3 in the incidence of severe hypertension (10.6%, 22.2%, and 52.1%), preterm preeclampsia with onset at <37 weeks of gestation (7.0%, 15.9%, and 20.4%), and small for gestational age (13.1%, 17.7%, and 21.1%), but not term preeclampsia with onset at ≥37 weeks of gestation (9.5%, 9.1%, and 6.6%). CONCLUSIONS: In women with prepregnancy chronic hypertension, the rates of development of severe hypertension, preterm preeclampsia, and small for gestational age are related to the use of antihypertensive medications and the level of blood pressure control at the first hospital visit during the first trimester of pregnancy.
引用
- Nzelu D, Dumitrascu-Biris D, Nicolaides KH, et al. Chronic hypertension: first-trimester blood pressure control and likelihood of severe hypertension, preeclampsia, and small for gestational age. Am J Obstet Gynecol. 2018. PMID: 29305253. doi:10.1016/j.ajog.2017.12.235
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。